Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Easily. Every day probably a new low and everyday pumpers will be talking about how they are buying more at this level. Rinse, repeat.
Exactly. The posters on here are learning to be as scummy and sneaky as the company they are pumping.
Oh well I surely believe a reddit post about a stock, jfc.
Really? Because I just spoke with him and he said he hadn't talked to any other investors today.
I suppose you think it's also libel to say that they haven't gotten past mice trials for their cancer treatment in 10 years, right?
It is amazing how some people will lie to try and make a point.
Yeah no worries. I am extremely salty on this stock partially because many long posters won't say a bad thing about this company in spite of a lot of evidence that shows they consistently screw share holders. Also, not to mention the fact that they have never followed up on the mice trials for adva-27a or sbfm-pl4, there merely announce new trials for related compounds for the same ailments, which, given they have been testing adva-27a on cancer for over 10 years, at some point has to trigger the notion that this company will never produce anything viable.
Instead, what I suspect, they are in deep and just want to pump it to get out and so they have to play the game of pretending this is on the cusp of something great to get new stooges in that they can dump to. Either that or they are wildly addicted to hopium. In either case I have tried to maintain a neutral, unbiased assessment of this stock over the year and 3 months I have been invested. 6-8 months ago I was cautiously optimistic, but after no progressive news on any of their drug trials, PRs that promise new in vitro tests (what about the old mice trials?), plus the fuckery with the ever-changing last minute reverse split ratio increase and offering that netted far less than it initially touted it would make and the plummeting stock price after the reverse-split, this company gets no more optimism until they actually show progress yo phase 1 trials.
Which according to that article is roughly a year away, all while Dr Slilaty is in his 70s. Meanwhile you have people excited about the possibility of this doubling in price or maybe even hitting $15, all while they talked about this going to $5 easily well before the reverse split. That kind of mentality, along with their renewed hope after all the blatant BS and I can't take these people seriously in any regard.
According to this article in USA today:
https://www.usatoday.com/story/sponsor-story/sunshine-biopharma/2022/04/13/meet-biotech-firm-sunshine-biopharma-changing-health/9468265002/
I thought I read the 9-18 month time-frames for phase 1 clinicals in an official sec filing, but I don't recall if it was an annual 10k or some other form.
As it pertains to the shareholders you can boil it down to how much value they removed packaging two warrants with each share on the offering. That is exactly what we are talking about, is shareholder value. This company consistently destroys the value of it's shareholders while making no progress in the state of it's cancer treatment. Over 10 years and still stuck in mice trials, while regurgitating the "destroys cancer cells in vitro" from over 10 years ago. The only thing this stock is good for is a couple pumps and dumps a year.
How many shares did you have pre-split vs post-split?
Divide $15 by 200.
Well here's the thing about it. I realized that the deal for the $122k debt buy off happened smack dab in between two 20:1 reverse splits, which is why a 13g was never filed. Imagine that this company doing two reverse splits in consecutive years. Either way this company is garbage and can't seem to get by without reverse splitting their shares at every turn.
Remember when everyone on here thought this was going from pennies to dollars? Now people can only hope it doubles it's share price. Either way the company screwed over everyone and the potential for profits is maybe to double up. Most longs here thought this was an easy millionaire-making stock. Now it's going to be at least a year before they even get to phase 1 trials, if that even happens.
This thing has to hit $60 to equate to the ATH of $0.30 when it was on the OTC, before the 200:1 reverse split. Reverse splits seem to be the only thing this company can actually complete, because they've been working this cancer angle for 10 years without ever getting past mice trials.
Yeah and he has been plenty outspoken about it. Sunshine, not so much.
It clearly states on the otcqb certification, which I linked in a prior post that the deal was made on December 31 2019 and the notes were converted a year later in 2020 in the form of 121 million shares. Read the file, page 4
He is going to say whatever he needs to to keep up his appearances as an investor that isn't doing shady shit. He does back door deals then does big pump PRs so he can dump his cheap shares for profit.
No it clearly states in the OTCQB certification that he was issued 121 million shares for $122k. Read the damn file. December 31, 2019. It's old news, but it is absolutely true.
Oh yeah? Check out their OTCQB filing from last year (from the failed attempt to uptier).
I'll even provide a link:
https://www.otcmarkets.com/otcapi/company/financial-report/277951/content
On page 4, the last page, it shows all the debt and shares they have had dating back to April 2017.
If you look at the list on December 31, 2019 RB Capital bought 121 million shares at $0.001 per share to buy out $122k worth of debt. Those shares matured in December 2020 and in 2021 we got the announcement that RB Capital was going to give $2 million to fund Sunshine Biopharma. He already had 121 million shares at that point for $0.001 per share. You can bet he sold a bunch on the first spike to $0.30, hell at that point he could have sold 20 million of his 121 million shares and tripled his return from the $2 million investment his company made in 2021. He would still have 100 million shares left over at the $0.001 rate plus the shares that he was eligible for from the $2 million in funding he entered into a deal with that same year.
If he sold half of his 121 million shares he would have made a staggering $18 million. He bought a boatload of shares cheap in 2019, they matured by 2020, then he pumped the shit out of it with a $2million dollar investment that pumped the price up and he sold the shares he got at dirt cheap from 2 years prior. I would wager a $2 million loan on a return of up to $30 million any day.
Lol, he was real honest! Are you serious? How could you tell he was honest?
Also, not worth mentioning? Why because people will either see he is a shit investor or will realize he is a scam artist and pumped the stock with $2 million financing shortly after he bought hundreds of millions of shares for less than a penny when he bought some old debt back in 2020? He made out like a bandit and is playing the sting to keep up appearances so he can scam other investors on his many other scam stocks. Seriously, have you looked at any of the other stocks he tweets about? They are all down after huge spikes. Soon he will add more to that list.
Really? How do you know? I noticed he doesn't list sbfm anymore in his tweets of companies he is invested in. Why do you think that is? He dumped a while ago and had to play the part that he still had shares so as not to expose himself as a scammer. It's all part of the sting of taking people's money.
My proof is in the share price and lack of news. Where's your proof? What about sbfm-pl4 mice trials? I thought those were done last year? All offerings and quiet periods are done now, too. So what's the excuse on them not releasing any info on how those mice trials went?
Deep in denial is where you are at because you know I was right all along.
And where's your beloved Brett Rosen? He doesn't mention sbfm at all anymore, probably because he dumped his shares and took his money, probably part of the reason this company has fallen so low, he had a lot of shares... Not likely anymore.
You will be waiting the rest of your life if you think this company is going to do anything positive with their share price.
Of course because if you were talking about the price you would have to acknowledge how this company absolutely shit the bed.
From an article that is 2 months old. And they have been so successful with their other COVID treatment sbfm-pl4, so much so that they haven't mentioned it in over a year since it began mice trials. Lol, what a joke, this stock has fallen so ridiculously far and you flippers are still here pretending like none of it has ever happened.
Hey look at the price continue to plummet. You sure we're right about this stock for over 2 years, what a winner!
It wasn't even mentioned in that article and what a 2-bagger? If it hits it out of the park? Something that started mice trials over a year ago and hasn't been mentioned since might double the price, which is at a low of $2.70? Yikes, how low the bar has fallen from the days of the OTC when the talk was .30 to $5 plus easily, now after a 200:1 reverse split and the price plummeting, you think almost $6 will be likely if a compound that hasn't been mentioned in over a year since mice trials began hits it out of the park. Lol. That's sad.
Where are all the pumpers from the weekend? Look at how high this is rocketing!!
Revenue coming from vitamins? Their net revenue last year was $228k. Their net loss was $12 million. Those vitamins don't even dent their costs. Also they are $30 million in debt according to last year's 10K and they still haven't even started phase 1
They have been pre-clinical for the last 10 years and have stated in 10Ks as far back as 2012 that they intend to start phase 1 and it will take 18 months. 10 years later that is still where this company is at.
That was on the OTC and before they added more shares in the new offerings. This thing ain't jumping to $60 a share on Phase 1 news and zero products or revenue
Not likely to have any where near that kind of price increase until at least phase 2 trials, which means it's at least 18 months away and they haven't even announced any phase 1 trials. And that's just to get back to the all time high that none of the longs here sold at because they thought this would jump to $5 from .20-.30, which in itself is a 2000% increase. So maybe in 3 years you will see a 2000% or more increase if everything goes right, and so far, with this company almost nothing has gone right besides them being able to barely crawl into the Nasdaq.
They would need a 2000% increase to get back to where they were at the ATH pre-reverse split.
Sorry dropped by 95% not 2000%
Dropped way out of sight? Like a drop from "$18" a year ago to $3 today? Or if we actually figure that $18 price point with the 200:1 reverse split, its more like a drop from $0.09 to $0.015? Or for those who actually remember what the high was a year ago a drop from $0.30 to $0.015 given they packaged 2 warrants with each share on the initial offering on uplist to nasdaq. In other words a 2000% drop from a year ago. I'd hate to see what you consider out of sight as this teeters around $3 with 2000% share value lost in a year span thanks to shady dilution, offering uplist and warrant packaging.
And so far the science hasn't worked enough to get to phase 1 trials for 10 years
Exactly. I hope they have something and are finally moving forward, but looking at their history of claiming they expect to go to phase 1 trials soon is like a broken record. The two examples from the old SEC filings aren't the only times they published the intent to go to Phase 1 trials, I just didn't feel like pulling up every single one of them.
Fact of the matter is people quoting them saying the same thing again doesn't mean jack sh!t until they actually show some real progress, something they have never done. Whatever happened to the COVID Mice trials? What about the Adva-27a mice trials that started shortly after the COVID trials last February?
And then instead of an update on either of those we get the mRNA cancer trials which parrot the same cancer-killing ability that the adva-27a cancer treatment already claimed. Doesn't seem like progress, more like redressing old news in some buzzword that has a bunch of hype because of the pandemic. Yet all the pumpers here are quoting this as if it's some miracle cure, when history shows this company has been stuck at this point for 10 years and claiming nothing different.
Here is a link to all their past sec filings:
https://sunshinebiopharma.com/sec-filings/
If you go through all the 10Ks you will find they consistently say they expect to start Phase 1 trials and that they will take roughly 18 months to complete.
Here's a 10Q from August 2014, saying they expect to do Phase 1 trials in 2015:
https://sunshinebiopharma.com/assets/secfilings/sunshine_final.pdf
"Clinical Trials
Adva-27a’s initial indication will be pancreatic cancer and multidrug resistant breast cancer for which there are currently little or no treatment options. In
June 2011 we concluded an agreement with McGill University’s Jewish General Hospital in Montreal, Canada to conduct Phase I clinical trials for this indication. All
aspects of the planned clinical trials in Canada will employ U.S. Food and Drug Administration (“FDA”) standards at all levels. As a result of the Dutchess
Agreement described below, we now anticipate that Phase I clinical trials will commence in mid to late 2015 and we estimate that it will take 18 months to complete, at
which time we, together with our licensor, expect to file for limited marketing approval with the regulatory authorities in Canada and the FDA in the
U.S. See “Marketing,” below."
That's on page 14 under Clinical Trials section.
And here's a 2011 November 10Q link:
https://sunshinebiopharma.com/assets/secfilings/77385%20-%20Sunshine%20Edgar_FINAL.pdf
Also from page 14 under Clinical Trials section. The last sentence of that section.
"We anticipate the clinical trials will be completed by late 2014, at which time we, together with our licensor, expect to file for limited marketing approval with the
regulatory authorities in Canada and the FDA in the U.S. (see Marketing below)."
They have been saying they expect to go to Clinical trials for over 10 years and never have and have no problem posting that in 10Qs without ever delivering. So tell me more about how they promised to go to Phase 1 trials soon.
They can't get past mice trials in 10 years
Finishing his work? They haven't made any progress on the cancer drug in 10 years.
No it means that if he retires this company, as they have stated many times in PRs, 8Ks and 10Qs in the past, that if Slilaty ever leaves the company it will do irreparable damage to their ability to be profitable.